The FDA has slapped a clinical hold on Rocket Pharmaceuticals’ pivotal gene therapy trial in response to a death. Rocket, ...

Artificial Intelligence (AI) has rapidly evolved from a promising technology to a core enabler of innovation in the pharmaceutical industry. Today, AI is estimated to generate between $350 billion and ...

Michael Yee, Jefferies senior biotech analyst, joins CNBC's 'Squawk on the Street' to discuss how AI could fuel drug ...

Biotech, one of the Bay Area's most important industries, sprang up in five short decades. Here are the key moments to know ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has entered a key licensing agreement with Telesis Bio Inc. to integrate the ...

Moleculin Biotech Inc (MBRX) progresses with key trials and regulatory approvals, but faces financial hurdles and operational ...

Viva Biotech launches AI-driven drug discovery platform, transforming new drug R&D logic, enabling one-stop innovative drug discovery: Shanghai, China Friday, May 16, 2025, 12:00 ...

VTV's blended value approach, attractive dividend yield, and lower volatility make it a strong core holding amid economic ...

The FDA announced yesterday that it will limit access to Covid-19 vaccines to people 65 years of age and older and others who ...